Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine

Cardiovascular Research

Volumn 89, Issue 4, 2011, Pages 862-869

  Noujaim, Sami F ^a   Stuckey, Jeanne A ^a   Ponce Balbuena, Daniela ^b   Ferrer Villada, Tania ^b   López Izquierdo, Angelica ^b   Pandit, Sandeep V ^a   Sánchez Chapula, José A ^b   Jalife, José ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSIDAD DE COLIMA   (Mexico)

Author keywords

Chloroquine; Fibrillation; Inward rectifier potassium current; Quinidine

Indexed keywords

CHLOROQUINE; DOCKING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; LIGAND; POTASSIUM; POTASSIUM CHANNEL; QUINIDINE; QUINOLINE;

ARTICLE; CELL FUNCTION; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART FIBRILLATION; HUMAN; HUMAN CELL; ION CURRENT; ION TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM; TACHYCARDIA; UPREGULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHLOROQUINE; MICE; MODELS, MOLECULAR; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; QUINIDINE;

EID: 79951917665     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr008     Document Type: Article

References (30)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A et al. Prevention of atrial fibrillation: Report from a National Heart, Lung, and Blood Institute Workshop. Circulation 2009;119:606-618.
2. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-1116.
3. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992;20:527-532.
4. Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro J, Dumaine R et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 2005;16:54-58. (Pubitemid 40165452)
5. Giustetto C. Quinidine to treat short QT syndrome: a real alternative to ICD? In: Raviele A, ed. Cardiac Arrhythmias. Italy: Springer Verlag, 2005:p333-335.
6. Kaufman ES. Quinidine in short QT syndrome: an old drug for a new disease. J Cardiovasc Electrophysiol 2007;18:665-666. (Pubitemid 46800514)
7. Burrell ZL Jr, Martinez AC. Chloroquine and hydroxychloroquine in the treatment of cardiac arrhythmias. N Engl J Med 1958;258:798-800.
8. Rodriguez-Menchaca AA, Navarro-Polanco RA, Ferrer-Villada T, Rupp J, Sachse FB, Tristani-Firouzi M et al. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci USA 2008;105:1364-1368. (Pubitemid 351397059)
9. Noujaim SF, Stuckey JA, Ponce-Balbuena D, Ferrer-Villada T, Lopez-Izquierdo A, Pandit S et al. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets. FASEB J 2010;24:4302-4312.
10. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005;96:800-807. (Pubitemid 40559520)
11. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005;332:1012-1019. (Pubitemid 40798187)
12. Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA et al. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 2005;8:279-287. (Pubitemid 40300184)
13. Li J, McLerie M, Lopatin AN. Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability. Am J Physiol Heart Circ Physiol 2004; 287:H2790-H2802. (Pubitemid 39557153)
14. Noujaim SF, Pandit SV, Berenfeld O, Vikstrom K, Cerrone M, Mironov S et al. Up-regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotors. J Physiol 2007;578:315-326. (Pubitemid 44971128)
15. Schuttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2004;60: 1355-1363. (Pubitemid 41079731)
16. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998;19:1639-1662. (Pubitemid 128590223)
17. Brunger AT, Admas PD, Clore GM, Delano WL, Gros P, Grosse-Kunstleve RW et al. Crystallography and NMR system (CNS): a new software system for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998;D54:905-921.
18. Vaidya D, Morley GE, Samie FH, Jalife J. Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 1999;85:174-181.
19. Samie FH, Berenfeld O, Anumonwo J, Mironov SF, Udassi S, Beaumont J et al. Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res 2001;89:1216-1223. (Pubitemid 34627881)
20. Sanchez-Chapula JA, Salinas-Stefanon E, Torres-Jacome J, Benavides-Haro DE, Navarro-Polanco RA. Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes. J Pharmacol Exp Ther 2001;297:437-445. (Pubitemid 32242605)
21. Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G et al. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 2007;18:658-664. (Pubitemid 46800513)
22. Warren M, Guha PK, Berenfeld O, Zaitsev A, Anumonwo JM, Dhamoon AS et al. Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart. J Cardiovasc Electrophysiol 2003;14:621-631. (Pubitemid 36733543)
23. Clark RB, Sanchez-Chapula J, Salinas-Stefanon E, Duff HJ, Giles WR. Quinidine-induced open channel block of K+ current in rat ventricle. Br J Pharmacol 1995;115:335-343.
24. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 2003;111:1529-1536. (Pubitemid 38063285)
25. Logothetis DE, Jin T, Lupyan D, Rosenhouse-Dantsker A. Phosphoinositide-mediated gating of inwardly rectifying K+ channels. Pflugers Arch 2007;455:83-95. (Pubitemid 47403981)
26. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev 2005;85:1205-1253. (Pubitemid 41362269)
27. Nerbonne JM. Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol 2000;525:285-298. (Pubitemid 30398360)
28. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002;110:381-388. (Pubitemid 34847970)
29. Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005;111:2720-2726. (Pubitemid 40791541)
30. Fodstad H, Swan H, Auberson M, Gautschi I, Loffing J, Schild L et al. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome. J Mol Cell Cardiol 2004;37:593-602. (Pubitemid 38953386)